欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/1299/001
药品名称Trabectedin EVER Pharma 0.25 mg powder for concentrate for solution for infusion
活性成分
    • TRABECTEDIN 0.25 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人Ever Valinject GmbH Oberburgau 3, 4866 Unterach am Attersee, Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Trabectedin EVER Pharma
    • Hungary (HU)
    • Germany (DE)
      Trabectedin EVER Pharma 0,25 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
    • Czechia (CZ)
      Trabectedin Ever Pharma 0.25 mg Prášek pro koncentrát pro infúzní roztok
    • Belgium (BE)
    • Romania (RO)
      Trabectedin EVER Pharma 0,25 mg pulbere pentru concentrat pentru soluţie
    • Netherlands (NL)
    • Slovakia (SK)
    • France (FR)
    • Slovenia (SI)
    • Spain (ES)
    • Croatia (HR)
    • Portugal (PT)
许可日期2023/02/22
最近更新日期2024/08/02
药物ATC编码
    • L01CX01 trabectedin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase